178.20p+3.80 (+2.18%)26 May 2022, 17:54
Find out how to deal online from £1.50 in a SIPP, ISA or Dealing account.

Puretech Health PLC Market & Company News

12:05PRTCAkili & Roblox (NYSE:RBLX) Partner on EndeavorRxReach
07:00PRTCTransaction in Own SharesRNS
25.05.2022 10:18TYMN, TRST, RNKCentrica and Johnson Matthey indicated to join FTSE 100, Asos in 250Alliance
25.05.2022 07:00PRTCTransaction in Own SharesRNS
24.05.2022 08:05PRTCPRTC's Vedanta Presents Data at DDW Annual MeetingReach
24.05.2022 07:00PRTCTransaction in Own SharesRNS
23.05.2022 07:00PRTCTransaction in Own SharesRNS
20.05.2022 07:00PRTCTransaction in Own SharesRNS
19.05.2022 07:00PRTCPDMR Notification RSU VestingRNS
19.05.2022 07:00PRTCTransaction in Own SharesRNS
18.05.2022 07:00PRTCTransaction in Own SharesRNS
17.05.2022 12:00PRTCPRTC to Present at UBS Healthcare ConferenceReach
17.05.2022 07:00PRTCTransaction in Own SharesRNS
16.05.2022 14:30PRTCPRTC Presents LYT-100 Data at ATS ConferenceReach
16.05.2022 07:00PRTCTransaction in Own SharesRNS
13.05.2022 07:00PRTCTransaction in Own SharesRNS
12.05.2022 07:00PRTCTransaction in Own SharesRNS
11.05.2022 07:00PRTCTransaction in Own SharesRNS
10.05.2022 07:00PRTCTransaction in Own SharesRNS
09.05.2022 07:00PRTCPRTC Share Buyback Programme Commences PurchasesRNS
05.05.2022 12:26PRTC, NXT, EDVLONDON MARKET MIDDAY: Shares up, pound down as BoE hikes rates to 1%Alliance
05.05.2022 11:18PRTCIN BRIEF: PureTech shares rise as unveils USD50 million share buybackAlliance
05.05.2022 07:00PRTCPRTC Announces Share Buyback Programme Up to $50MRNS
04.05.2022 13:35PRTCPureTech entity Gelesis reports positive data for weight loss drugAlliance
04.05.2022 11:35PRTCGelesis Presents GS200 Weight Loss Data at ECOReach
03.05.2022 07:00PRTCTotal Voting RightsRNS
29.04.2022 11:05PRTCGelesis Data: Therapeutic Shows Gut Health BenefitReach
27.04.2022 09:42RTN, ESP, S32LONDON BROKER RATINGS: Bank of America cuts Melrose, raises SpectrisAlliance
26.04.2022 18:03AXL, GMR, IMMOTRADING UPDATES: Billington faces headwinds; Immotion plans spin-offAlliance
26.04.2022 07:00PRTCPRTC Final Results & Publication of Annual ReportRNS
19.04.2022 16:02RWS, PRTC, NOGUK earnings, trading statements calendar - next 7 daysAlliance
13.04.2022 18:47DIS, PRTC, MXCTTRADING UPDATES: BlueRock output rises; Watkin Jones profit to fallAlliance
13.04.2022 16:44PRTCPRTC's Vedanta Publishes VE303 DataReach
12.04.2022 21:51CEPS, MGAM, PFPTRADING UPDATES: Gore Street fundraise; Pathfinder mulls disposalAlliance
12.04.2022 12:05PRTCAkili Depression Data Published in AJPReach
12.04.2022 07:00PRTCGlyph: 20x Oral Bioavailability of BuprenorphineReach
07.04.2022 07:00PRTCNotice of ResultsRNS
01.04.2022 07:00PRTCTotal Voting RightsRNS
24.03.2022 07:00PRTCPRTC Appoints Merck Vet to BOD & Audit CommitteeRNS
18.03.2022 20:38PCIP, UOG, SCIRTRADING UPDATES: Angle US lab boost; Corcel to capitalise on nickelAlliance
17.03.2022 13:05PRTCAkili Adds Gaming Vet as Chief Product OfficerReach
16.03.2022 10:35PRTCGelesis: Record-Breaking Plenity PrescriptionsReach
08.03.2022 12:05PRTCAkili Named to World's Most Innovative CompaniesReach
18.02.2022 16:30PRTCHolding(s) in CompanyRNS
17.02.2022 12:05PRTCAkili Data: Enhanced Brain Activity in Kids w/ADHDReach
15.02.2022 07:00PRTCPRTC's Akili Files Registration Statement on S-4Reach
10.02.2022 12:00PRTCPRTC to Present at Leerink Healthcare ConferenceReach
04.02.2022 14:51PRTCIN BRIEF: PureTech Health operations chief buys GBP50,000 in sharesAlliance
04.02.2022 09:34BGO, TLW, ENQLONDON BROKER RATINGS: Goldman starts Ceres at Sell, ITM at NeutralAlliance
31.01.2022 11:50PRTCPRTC's Gelesis Launches Plenity Media CampaignReach
26.01.2022 12:02PRTCPRTC’s Akili to Become Public & $162M FundingRNS
14.01.2022 07:00PRTCPRTC's Gelesis to Debut on NYSE Today Ticker GLSRNS
07.01.2022 12:00PRTCPureTech to Present at JPM Healthcare ConferenceReach
06.01.2022 07:00PRTCLYT-100 Shows Improved AE Profile vs PirfenidoneReach
05.01.2022 12:05PRTCGelesis Adds to BOD & Declared Effective by SECReach
16.12.2021 07:00PRTCPRTC Provides Recap Ahead of Catalyst-Rich 2022Reach
08.12.2021 12:00PRTCPRTC Presents Data at ACNP Conference For LYT-300Reach
07.12.2021 12:00PRTCPRTC's Lymphatic Platform Candidate Human StudyReach
01.12.2021 12:10PRTCPRTC: Gelesis' Plenity Now Broadly Available in USReach
01.12.2021 07:00PRTCTotal Voting RightsRNS
18.11.2021 12:10PRTCPRTC's Gelesis Receives $30M Plenity Order from RoReach
16.11.2021 12:00PRTCPRTC Publishes Previous LYT-100 MAD Study ResultsReach
15.11.2021 12:00PRTCPRTC Presents at Two Upcoming Investor ConferencesReach
12.11.2021 12:00PRTCPRTC Presents Immunooncology Ph 1/2 Trial at SITCReach
11.11.2021 12:00PRTCFDA Grants PRTC's LYT-200 Orphan Drug DesignationReach
10.11.2021 07:00PRTCPRTC Receives $100M from Founded Entity SharesRNS
09.11.2021 12:34PRTCKRTX and Zai Lab to Develop KarXT in Greater ChinaReach
09.11.2021 07:00PRTCPRTC Presents at Jefferies Healthcare ConferenceRNS
01.11.2021 10:20PRTCNew Research in Journal Nature on Gelesis TechReach
01.11.2021 07:00PRTCTotal Voting RightsRNS
22.10.2021 18:00PRTCHoldings in Company - TR-1 Correction AnnouncementRNS
20.10.2021 16:35PRTCPrice Monitoring ExtensionRNS
14.10.2021 12:01PRTCPRTC's Vedanta Appoints Chief Legal OfficerReach
Showing 1 to 75 of 138